Related Experiment Videos
Cyclic AMP and c-myc gene expression in PY815 mouse mastocytoma cells
Abstract:
The possibility was examined that inhibition of growth of PY815 mouse mastocytoma cells by N6,O2'-dibutyryladenosine 3',5'-cyclic monophosphate (DB cyclic AMP) results from inhibition of c-myc gene expression. Temporary increases in c-myc RNA which occurred soon after DB cyclic AMP treatment and upon removal of the drug were not consistent with direct inhibition of c-myc gene expression by DB cyclic AMP. The increases in c-myc RNA coincided with the passage through, or accumulation of cells in late G1-early S phase. It is proposed that cyclic AMP may stimulate c-myc gene expression which normally occurs only in late G1-early S phase in PY815 cells and that cyclic AMP prevents c-myc expression in cells at other phases of the cell cycle by inhibiting their progression past a cyclic AMP-sensitive restriction point in early G1 phase.
Insights
N6,O2'-dibutyryladenosine 3',5'-cyclic monophosphate (DB cyclic AMP) does not directly inhibit c-myc gene expression in PY815 cells. Instead, DB cyclic AMP likely halts cell cycle progression in early G1 phase, indirectly affecting c-myc expression.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- N6,O2 omino-dibutyryladenosine 3 omino,5 omino-cyclic monophosphate (DB cyclic AMP) is known to inhibit the growth of PY815 mouse mastocytoma cells.
- The precise mechanism by which DB cyclic AMP inhibits cell growth is not fully understood.
- c-myc gene expression is a critical regulator of cell proliferation and is often dysregulated in cancer.
Purpose of the Study:
- To investigate whether the growth inhibitory effects of DB cyclic AMP on PY815 cells are mediated by the inhibition of c-myc gene expression.
- To elucidate the relationship between DB cyclic AMP treatment, cell cycle progression, and c-myc RNA levels in PY815 cells.
Main Methods:
- Treatment of PY815 mouse mastocytoma cells with DB cyclic AMP.
- Measurement of c-myc RNA levels using techniques such as Northern blotting or RT-qPCR.
- Cell cycle analysis using flow cytometry to assess cell cycle phase distribution.
Main Results:
- Temporary increases in c-myc RNA were observed shortly after DB cyclic AMP treatment and upon drug removal.
- These transient c-myc RNA increases were not consistent with direct inhibition of c-myc gene expression by DB cyclic AMP.
- The observed increases in c-myc RNA correlated with cells entering or accumulating in the late G1-early S phase of the cell cycle.
Conclusions:
- DB cyclic AMP does not directly inhibit c-myc gene expression in PY815 cells.
- Cyclic AMP may stimulate c-myc gene expression, which is typically restricted to the late G1-early S phase.
- DB cyclic AMP likely prevents c-myc expression in cells at other cell cycle stages by inhibiting progression through a cyclic AMP-sensitive restriction point in early G1 phase.